Journal articleClin Cancer Res2019

Oncogenic NRG1 Fusions: A New Hope for Targeted Therapy in Pancreatic Cancer.

DOI 10.1158/1078-0432.ccr-19-1280 ↗ OpenAlex, retrieved 5 November 2026

Journal: Clin Cancer Res
Published: 4 June 2019
Citations: 22
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Trials 1

BackgroundUsing Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620 ↗

Grants 3

Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer K08CA218420 ↗
Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma P50CA127003 ↗
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens U01CA224146 ↗